SCHEMBL7675052

SCHEMBL7675052

COc1ccc([Se](=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 7/20 0.61
▸ CA2 P00918 7/20 0.61
▸ CA9 Q16790 3/20 0.61
▸ CA7 P43166 2/20 0.61
▸ CA12 O43570 1/20 0.61
▸ CA14 Q9ULX7 1/20 0.61
▸ ACHE P22303 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.48
▸ CYP2A6 P11509 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ CES2 O00748 1/20 0.48
▸ CES1 P23141 1/20 0.48
▸ TDP1 Q9NUW8 3/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29175682 0.91 CA4 (0.56) CA1CA2CA9CA7CA12
SCHEMBL11130505 0.82 CA1 (0.52) CA1CA2CA9CA7CA12
SCHEMBL1128202 0.80 CA1 (0.65) CA1CA2CA9CA7CA12
1,4-Dimethoxybenzene SCHEMBL21802643 0.78 CA1 (1.00) CA1CA2CA9CA7CA12
1,4-Dimethoxybenzene SCHEMBL8489 0.78 CA1 (1.00) CA1CA2CA9CA7CA12
SCHEMBL28698839 0.76 CA1 (0.58) CA1CA2CA9CA7CA12
1,4-Dimethoxybenzene SCHEMBL29937047 0.75 CA1 (0.92) CA1CA2CA9CA7CA12
1,4-Dimethoxybenzene SCHEMBL30704776 0.75 CA1 (0.92) CA1CA2CA9CA7CA12
1,4-Dimethoxybenzene SCHEMBL28833370 0.72 CA1 (0.85) CA1CA2CA9CA7CA12
1,4-Dimethoxybenzene SCHEMBL11373286 0.72 CA1 (0.85) CA1CA2CA9CA7CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115058143-A Electromagnetic wave absorbent, preparation method thereof and method for preparing wave-absorbing coating by using electromagnetic wave absorbent 晶展(哈尔滨)科技有限责任公司 2022-09-16 — — CN claimed
CN-113200899-A Aryl selenide compound and synthetic method thereof 成都理工大学 2021-08-03 — — CN claimed
CN-108627654-B Composition for eliminating interference of calcium dobesilate medicine on creatinine enzymatic detection 武汉瀚海新酶生物科技有限公司 2021-03-16 — — CN claimed
EP-2872477-B1 PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL LEO LABORATORIES LTD (IE) 2018-09-05 — — EP claimed
US-9624157-B2 Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol LEO LABORATORIES LIMITED (IE) 2017-04-18 — — US claimed
US-20150329463-A1 PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL LEO LABORATORIES LIMITED (IE) 2015-11-19 — — US claimed
EP-2872477-A1 PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL Leo Laboratories Limited (IE) 2015-05-20 — — EP claimed
WO-2014012836-A1 PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL LEO LABORATORIES LIMITED (IE) 2014-01-23 — — WO claimed
JP-58057372-A — — None — — JP disclosed
CN-115058143-A Electromagnetic wave absorbent, preparation method thereof and method for preparing wave-absorbing coating by using electromagnetic wave absorbent 晶展(哈尔滨)科技有限责任公司 2022-09-16 — — CN disclosed
CN-114174479-B Lubricating oil additive and lubricating oil composition containing same 株式会社ADEKA 2022-08-23 — — CN disclosed
CN-114174480-B Lubricating oil additive and lubricating oil composition containing same 株式会社ADEKA 2022-08-23 — — CN disclosed
CN-114174479-A Lubricating oil additive and lubricating oil composition containing same 株式会社ADEKA 2022-03-11 — — CN disclosed
CN-114174480-A Lubricating oil additive and lubricating oil composition containing same 株式会社ADEKA 2022-03-11 — — CN disclosed
US-6352959-B1 HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-03-05 — — US disclosed
EP-1144401-A2 THIOCHROMANOYL CYCLOHEXENONE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-10-17 — — EP disclosed
EP-1135385-A1 THIOCHROMANOYLPYRAZOLONE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-09-26 — — EP disclosed
WO-2000035903-A2 THIOCHROMANOYL CYCLOHEXENONE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-06-22 — — WO disclosed
WO-2000034270-A1 THIOCHROMANOYLPYRAZOLONE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-06-15 — — WO disclosed
JP-S5857372-A PREPARATION OF 1,2,4-THIADIAZOLE COMPOUND, 1,2,4- THIADIAZOLINE COMPOUND OR 1,2,4-THIADIAZOLIDINE COMPOUND NITTO CHEM IND CO LTD 1983-04-05 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329463-A1 PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL TRIM25, UTP20, RARA CA1 3933/4885CA2 3329/4885CA9 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback